KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Depreciation and Depletion: 2009-2024

Historic Depreciation and Depletion for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to $190.2 million.

  • Charles River Laboratories International's Depreciation and Depletion fell 7.63% to $44.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $180.9 million, marking a year-over-year decrease of 3.93%. This contributed to the annual value of $190.2 million for FY2024, which is 7.64% up from last year.
  • Latest data reveals that Charles River Laboratories International reported Depreciation and Depletion of $190.2 million as of FY2024, which was up 7.64% from $176.7 million recorded in FY2023.
  • In the past 5 years, Charles River Laboratories International's Depreciation and Depletion ranged from a high of $190.2 million in FY2024 and a low of $123.0 million during FY2020.
  • Its 3-year average for Depreciation and Depletion is $174.7 million, with a median of $176.7 million in 2023.
  • Data for Charles River Laboratories International's Depreciation and Depletion shows a peak YoY increased of 14.39% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Charles River Laboratories International's Depreciation and Depletion stood at $123.0 million in 2020, then climbed by 14.39% to $140.7 million in 2021, then climbed by 11.80% to $157.3 million in 2022, then increased by 12.33% to $176.7 million in 2023, then climbed by 7.64% to $190.2 million in 2024.